Latest News
A combination of CBL0137 and panobinostat has been demonstrated to effectively treat neuroblastoma in mice. This combination therapy has the potential to lead the fight against this aggressive childhood cancer.
A research team has developed a new platform for performing chemotactic experiments in order to study neural regeneration mechanisms.
Not able to attend SfN 2018 this year? You can catch up with all the action from today with our daily video, best of social media and the biggest headlines.
Journal Articles
In this research article from Journal of Comparative Effectiveness Research, a new network meta-analysis compares lurasidone and brexpiprazole in acute schizophrenia.
In this research article from Pain Management, researchers investigate the effects of pregabalin, gabapentin and gastroretentive gabapentin on simulated driving performance.
This research article from Neurodegenerative Disease Management investigates how age and disease duration affects Parkinson’s treatment outcome with levodopa-carbidopa intestinal gel.
Autoimmune
Could hyaluronic acid contribute to chronic white matter injury?
Can living in a sunnier climate in your youth reduce the risk of MS?
Cerebrovascular disease
ANA 2018: key highlights and news stories
CNS/PNS/SNS
SfN18: Advances in brain–computer interfaces may improve therapies and prosthetics
Breakthrough spinal implant helps paralyzed men walk again
Spina bifida fetal surgery offered for the first time in the UK
Cognitive/neurodegenerative disorders
SfN18: What are the neural risks and benefits of marijuana use? New studies shed light
SfN18: New strategies for identifying causes of vascular dementia
SfN18: Exosomes could have wide-ranging and long-term effects in the brain and body
Demyelinating disease
Multiple sclerosis: potential risk factors, cognitive impairment and the microbiome
Identification of a new subtype of multiple sclerosis: an interview with Bruce Trapp
Development and pediatrics
SfN18: What are the neural risks and benefits of marijuana use? New studies shed light
SfN18: The adolescent brain, mental health and substance abuse
SfN18: The potential of gene therapy in neurological disorders
Epilepsy and seizure
Cannabidiol for epilepsy expected to be available within 6 weeks: industry news round-up
First FDA-approved cannabinoid-derived drug for seizures
Epilepsy and cannabinoids: current consensus, controversies and future outlook
Genetics
SfN18: The potential of gene therapy in neurological disorders
Treasure trove of 102 genes associated with autism identified
Monogenic neurodevelopmental disorders may not be as simple as they seem
Headache
Alzheimer’s drug development halted following toxic reaction: industry news round-up
Aimovig® receives EMA license for the prevention of migraine
Aimovig® receives positive CHMP opinion for the prevention of migraine
Immune disorders and inflammation
Inflammatory disease and anxiety: could endocannabinoids be a mechanism of comorbidity?
FENS 2018: Immune system offers new way of treating Alzheimer’s disease
FENS 2018: Could anxiety and inflammation be treated with cannabis?
Infection
ANA 2018: key highlights and news stories
Further evidence links herpes virus to Alzheimer’s disease
Could Alzheimer’s disease be kick-started by periodontal bacteria?
Injury/trauma
Breakthrough spinal implant helps paralyzed men walk again
Is brain cooling after a traumatic brain injury beneficial for patients?
Movement disorders
BrainStorm scraps initial access to NurOwn® for amyotrophic lateral sclerosis
Neuro-ophthalmology
Vision in Alzheimer's disease: a focus on the anterior afferent pathway
Glaucoma research gives a glimpse of a novel neuroprotection mechanism
Neurometabolic
Epigenetics, opioids and immune regulation: interviews from SfN17
Jeffrey Iliff: glymphatics, Alzheimer’s and future directions
SfN17: Neurodegeneration and the microbiome – new research highlights
Neuromuscular
New genetic suspects identified for ALS and FTD
Novel discovery in motor neuron disease may pave the way for future treatments
EAN 2017: Guillain-Barré syndrome risk associated with month of birth
Neuropsychiatry
SfN18: The adolescent brain, mental health and substance abuse
Combination therapy targeting the opioid system may help with major depression
Oncology/tumor
Could combination therapy be the future of neuroblastoma treatment?
Brain tumor liquid biopsies are on the horizon
Zika vaccine yields promising results for treating glioblastoma
Pain
Spinal cord stimulation enables paralyzed man to walk
Chronic pain relief: medical marijuana study identifies possible change in brain connections
NCTalks with Irene Tracey: lessons from pain, analgesia and anesthesia
Sleep
SfN18: Disrupted sleep may exacerbate anxiety and brain disorders
